Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve 1. Unaudited financial results for the quarter ended 30.09.2025.2. Limited Review Report for quarter ended 30.09.2025.3. Any other business with the permission of the Chair.
Vista Pharmaceuticals Ltd. Press Release Nov 04 2025
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Oct 14 2025
- Vista Pharmaceuticals Ltd. Press Release Sep 30 2025